📋 Material Events 2170

Extraordinary reports (臨時報告書) — AI-classified EDINET Doc 180 filings. ~1yr coverage, updated daily.

Date Company Category Summary Amount
2026-02-03
6503
🏗️ Business Suspension
The company implemented a 'Next Stage Support Program' special measure offering early retirement incentives to employees aged 53+ with 3+ years of service. A total of 2,378 employees applied during the recruitment period (December 15, 2025 - January 9, 2026), with retirement effective March 15, 2026. The company will record approximately 65 billion yen in special losses in the fiscal year ending March 2026.
¥65.0bn
2026-02-03
4967
💥 Impairment
Kobayashi Pharmaceutical has recorded impairment losses totaling 14,645 million yen on its consolidated financial statements for the fiscal year ending December 2025 due to reduced profitability forecasts for two pharmaceutical manufacturing facilities under construction: the Sendai New Factory in Miyagi Prefecture and the Thailand Factory operated by KOBAYASHI Pharmaceutical Manufacturing (Thailand) Co., Ltd. Both projects have experienced delays in quality management systems implementation and production timelines, requiring extended validation periods and increased costs beyond initial projections.
¥14.6bn
2026-02-03
4543
🤝 Merger
Kalila Medical, Inc., a wholly-owned subsidiary of the reporting company, was absorbed and merged into Terumo Medical Corp. (another subsidiary) effective January 31, 2026. As a result, Kalila Medical, Inc. ceased to exist as a separate legal entity and is no longer classified as a specific subsidiary of the reporting company.
2026-02-03
🏗️ Asset Sale
The company is selling a portion of its shares in Kanden Engineering Co., Ltd. (株式会社関電工), generating a gain on sale. The company expects to record 28.6 billion yen in special gains from securities sale proceeds in the individual financial statements for the fiscal year ending March 2026.
¥28.6bn
2026-02-03
6678
👤 Shareholder Rights
A change in major shareholder occurred following the completion of inheritance procedures on January 27, 2026. Masatomo Jitsuyoshi became the new major shareholder, increasing his voting rights from 2,253 shares (3.25%) to 11,416 shares (16.46%), succeeding the deceased major shareholder Shigeyuki Jitsuyoshi.
2026-02-03
9759
👤 CEO
The company announced the appointment of Hidetaka Kiwada as a new Representative Director (代表取締役) effective April 1, 2026, following a Board of Directors resolution on January 30, 2026. Kiwada will transition from his current position as Senior Executive Officer (専務執行役員) while maintaining his existing directorship, bringing extensive experience in advanced technology and innovation strategy.
2026-02-03
4005
💥 Impairment
The company recognized an impairment loss of 13,361 million yen on its equity investment in Rabigh Refining and Petrochemical Company (an equity method affiliate) due to significant decline in fair value of Class A ordinary shares. The impairment loss is recorded as a special loss in the individual financial statements for the third quarter of fiscal year 2026, but will be eliminated in consolidated financial statements with no impact on consolidated results.
¥13.4bn
2026-02-03
4438
💥 Impairment
The company recognized an impairment loss of 94 million yen on fixed assets (software, etc.) for the fiscal year ended December 2025. The impairment was recorded based on a careful review of future recoverability in light of recent business performance trends, in accordance with accounting standards for asset impairment.
¥94M
2026-02-03
💥 Impairment
The company's subsidiary Katsumi Global, LLC is significantly impacted by the Chapter 11 bankruptcy filing of its factoring client First Brands Group, LLC (FBG) in February 2026. FBG is under investigation for suspected fraud including inflated invoices, fictitious receivables, and multiple assignments of the same debt, with founders facing criminal charges. The company is recording an additional allowance for doubtful accounts of 150,458 million yen in Q3 FY2026.
¥150.5bn
2026-02-03 💰 Equity
The company is conducting a third-party allocation capital increase (新株式発行) on February 27, 2026, whereby Riken J Technologies LLC will acquire 62,500 voting rights (41.74% of total), becoming the new lead major shareholder. Consequently, individual shareholder Kazushi Watanabe will cease to be a major shareholder as his ownership percentage drops below 10% (from 13.65% to 7.95%).
2026-02-03
4188
🏗️ Business Suspension
Mitsubishi Chemical Group announced on February 2, 2026, that its subsidiary Mitsubishi Chemical Corporation will exit the coke and carbon material business (needle coke and pitch coke) produced at its Kagawa facility. The company expects to record approximately 85 billion yen in total non-recurring losses, including impairment losses of approximately 19 billion yen in Q3 FY2026 and approximately 66 billion yen in removal and employee support costs in Q4 FY2026.
¥8.5bn
2026-02-03
💥 Earnings Revision
One Fidelity Blue Chip Growth Stock Fund (bi-monthly settlement type with expected dividend presentation) filed its 12th calculation period report for the period from November 21, 2025 to January 20, 2026. The fund distributed 400 yen per 10,000 units and reported a period-over-period rate of change of 6.08%, with total net assets of approximately 47.6 billion yen and a unit price of 13,071 yen per 10,000 units as of the end of the period.
¥47.6bn
2026-02-03
💥 Earnings Revision
Shinko 7-Asset Balanced Fund filed an extraordinary report disclosing trust asset calculations and performance metrics for three consecutive calculation periods (227th-229th) ending January 20, 2026. The report details dividend distributions of 20 yen per 10,000 units, period-end net asset values ranging from approximately 4.8 to 4.9 billion yen, and period performance rates between 1.30% and 2.46%.
¥4.9bn
2026-02-02
2282
👤 CEO
The company announces a change in representative directors effective April 1, 2026. Maeda Fumio will assume the position of Representative Director and President, transitioning from his role as Senior Managing Executive Officer and Vice President. Ikawa Nobuhisa, the current Representative Director and President, will step down from the representative director position to become Chairman of the Board of Directors.
2026-02-02
6481
🤝 Divestiture
The company decided on February 2, 2026 to divest all issued shares and outstanding loans related to five subsidiary companies (TRA Holdings, THK Rhythm Automotive Canada, Czech, Germany, and Michigan operations) to AP87, a special purpose company indirectly backed by a fund managed by Advantage Partners. The divestiture also includes six indirect subsidiaries under TRA Holdings and is expected to close on June 1, 2026, with a material impact on the company's financial position and operating results.
2026-02-02
6971
👤 CEO
The company announced a management transition effective April 1, 2026, in which Shiro Sakurajima will become the new Representative Director and President (CEO), while Hideo Ina will become Representative Director Vice Chairman. The incumbent CEO Hideo Tanamoto will step down from the Representative Director position and retire as a director at the June 2026 shareholder meeting.
2026-02-02
7241
🏗️ Liquidation
The company's board of directors resolved on February 2, 2026 to initiate liquidation proceedings for its consolidated subsidiary Tianjin Shuangxie Machinery Industrial Co., Ltd. (天津双協機械工業有限公司). To address the subsidiary's debt-to-equity deficit, the parent company will convert it to a wholly-owned subsidiary and inject additional capital before commencing liquidation. The company expects to record approximately 3.0 billion yen in special losses related to the subsidiary's liquidation in the fiscal year ending March 2026, though this will be eliminated in consolidated financial statements.
¥3.0bn
2026-02-02
2760
👤 CEO
The company's board of directors approved changes to representative director positions effective April 1, 2026. Tokushige Atsuyuki transitions from Representative Director President/CEO to Representative Director Chairman/CEO, while Miyamoto Takayoshi is promoted from Director to Representative Director President/CEO. Hasegawa Masami transitions from Representative Director Executive Vice President to Director.
2026-02-02
9258
🤝 Acquisition
The company's subsidiary CS-R will acquire all shares of Gottsuu Co., Ltd. to make it a subsidiary. The acquisition is planned for mid-February 2026, with a total cost of approximately 153 million yen including stock acquisition price (120 million yen) and advisory fees (33 million yen).
¥153M
2026-02-02
7635
🤝 Acquisition
The company's board of directors resolved on February 2, 2026 to convene an extraordinary shareholders meeting on March 3, 2026 to approve a stock consolidation in connection with an MBO transaction. UMK Corporation launched a tender offer for all outstanding shares (excluding treasury stock and non-tendering shareholders' shares totaling 1,999,000 shares), acquiring 2,930,441 shares (54.62%) at 1,710 yen per share through December 25, 2025.
¥5.0bn
2026-02-02
7283
💰 Equity
Assan Industries resolved to dispose of treasury shares (320,800 shares) to the Assan Industries Employee Stock Ownership Association through a restricted stock incentive program for employees. The shares will be issued at 2,195 yen per share for a total amount of approximately 704.16 million yen, with a restriction period from July 1, 2026 to June 30, 2029.
¥704M
2026-02-02
5711
👤 Shareholder Rights
Silchester International Investors LLP, a major shareholder, has reduced its stake below the 10% threshold. The shareholding decreased from 133,525 voting rights (10.28% of total) as of January 13, 2026, to 117,466 voting rights (9.04% of total) as of January 28, 2026, resulting in the loss of major shareholder status.
2026-02-02
👤 CEO
The company's Board of Directors resolved on January 29, 2026 to change the Representative Director (CEO). Hirofumi Kuwata, currently Senior Vice President and Chief Operating Officer, will be promoted to Representative Director and President effective April 1, 2026. Takashi Maruyama, the current Representative Director and President, will transition to the role of Chairman of the Board.
2026-02-02
3622
💥 Earnings Revision
The company is recognizing advisory fees of 86 million yen as a special loss in FY2026 March period related to financial strategy consultations aimed at mid-to-long-term corporate value enhancement. This event materially impacts the company's financial condition, operating results, and cash flow situation.
¥86M
2026-01-30
9513
👤 CEO
J-Power (Electric Power Development Co., Ltd.) announced a change in representative director effective April 1, 2026. Hideaki Kato will succeed Hitoshi Sugano as Representative Director and President. Sugano will transition to President Executive Officer role while Kato will assume the title of President and Representative Director.
2026-01-30
8233
💰 Buyback
The company announced the repurchase and planned retirement of its 2028 maturity Euro yen-denominated convertible bonds with warrant rights. The total principal amount of bonds to be repurchased is 5,999.0 billion yen, with the repurchase to be completed on February 26, 2026, resulting in a special loss to be recorded in the February 2026 financial statements.
¥99.1bn
2026-01-30
6777
🤝 Divestiture
Santec Holdings approved an absorption-type spin-off effective April 1, 2026, transferring its asset management division to its wholly-owned subsidiary Aqumen Capital Co., Ltd. The spin-off is designed to consolidate asset management operations within the group, enhance asset efficiency, and strengthen the financial foundation for future business and growth investments. No consideration will be exchanged as the transaction involves only a parent and its wholly-owned subsidiary.
2026-01-30
2796
🤝 Acquisition
The company's board of directors resolved on January 30, 2026 to acquire all shares of Sanko Medical Co., Ltd., a pharmaceutical wholesaler, and make it a subsidiary. This acquisition is part of the company's mid-term management plan 'Make a Leap 2027' aimed at strengthening the group's pharmaceutical distribution system and expanding region-focused medical services in the Kanto region.
¥1600
2026-01-30
1964
👤 CEO
The company's Board of Directors resolved on January 30, 2026 to transition the representative director roles effective April 1, 2026. Akira Ozaki will move from Representative Director and President to Representative Director and Chairman, while Mamoru Sakata will be promoted from Director and Managing Executive Officer to Representative Director and President Executive Officer.
2026-01-30
👤 CEO
The company announced a change in representative director (CEO equivalent) effective April 1, 2026. Yutaka Kaiyama will assume the position of Representative Director and President, replacing Noriyuki Hara who will transition to Chairman. The parent company MS&AD Insurance Group Holdings approved the succession on January 30, 2026.
2026-01-30
2978
💰 Debt
Tsukuruba Box Co., Ltd., a subsidiary of Tsukuruba Co., Ltd., entered into an overdraft facility agreement with a major Japanese bank on January 30, 2026, for a maximum principal amount of ¥1,000 million. The facility is secured by a first-priority mortgage on the target real estate property and a joint guarantee from the parent company Tsukuruba Co., Ltd., with financial covenants including equity ratio maintenance, profit requirements, and inventory turnover ratio restrictions.
¥1.0bn
2026-01-30
7074
👤 Board
The company has resolved to replace its accounting auditor firm effective February 26, 2026, at the 18th Annual Shareholders Meeting. Yamato Audit Corporation, whose term ends on that date, will be replaced by San-Yu Audit Corporation after comparative evaluation of audit implementation体制, audit policies, quality management, and audit fees.
2026-01-30
1949
🤝 Acquisition
Sumitomo Electric Industries' subsidiary Sumitomo Densetsu has decided to issue A-class preferred shares to Daiwa House Industry for approximately 123 billion yen through third-party allotment. The proceeds will fund the acquisition of all ordinary shares held by Sumitomo Electric Industries, enabling Daiwa House to achieve complete subsidiary status following its successful public tender offer in December 2025.
¥123.0bn
2026-01-30
3465
💰 Debt
The company entered into a loan agreement with urban and system financial institutions on January 30, 2026, for 8.5 billion yen with repayment due March 31, 2027. The loan is secured by a blanket mortgage on land and includes financial covenants requiring maintenance of equity at 75% of baseline levels and preventing two consecutive periods of operating losses.
¥8.5bn
2026-01-30
6727
👤 Board
The company's Audit Committee has resolved to change its statutory auditor effective at the conclusion of the 43rd Annual General Meeting of Shareholders scheduled for late June 2026. PwC Japan Limited Liability Audit Corporation, which has served since July 11, 2006, will be replaced by Deloitte Touche Tohmatsu LLC (Limited Liability Ayusa Audit Corporation). The change is based on consideration of the current auditor's tenure and evaluation of multiple audit firms' proposals.
2026-01-30
6810
🤝 Divestiture
Maxell Corporation resolved to transfer its optical lens unit business (operated by the Optical & Systems Business Division) to its wholly-owned subsidiary Maxell Frontier Co., Ltd. through an absorption split, effective April 1, 2026. The transaction aims to integrate management resources and strengthen automotive optical components business by enabling more agile operations in response to market changes and customer needs.
2026-01-30
5027
🤝 Acquisition
The company decided on January 27, 2026 to acquire all shares of MISM Corporation through its wholly-owned subsidiary AnyMind Japan Corporation, thereby consolidating MISM as a subsidiary. MISM specializes in vertical video creative production and SNS marketing, with over 2,000 registered creators and annual production of 20,000+ videos, complementing the company's social commerce strategy.
¥645M
2026-01-30
5707
📋 Material Contract
The company amended the financial covenants in its creditor agreement dated February 14, 2025, with 14 financial institutions. Effective January 30, 2026, the amendment modified covenant (2) to include an additional credit facility (overdraft contract with Mitsubishi UFJ Bank) in calculating the minimum liquidity requirement of ¥8.5 billion, while maintaining other covenants unchanged.
¥7M
2026-01-30
3109
💰 Debt
The company executed a refinancing transaction under its commitment line agreement with 15 financial institutions. The company repaid 6,880 million yen of existing debt and simultaneously borrowed an equivalent new amount of 6,880 million yen to efficiently manage working capital. The borrowing is unsecured and matures on February 27, 2026.
¥6.9bn
2026-01-30
8604
🤝 Acquisition
The company completed the acquisition of all shares of Macquarie Management Holdings, Inc. on December 1, 2025. As a result, Delaware Management Company, a subsidiary of Macquarie, has become a specified subsidiary of the reporting company and requires disclosure under the Financial Instruments and Exchange Act. The acquired company operates investment management and advisory businesses in the United States with capital of USD 590 million.
2026-01-30
9434
👤 CEO
On January 29, 2026, the company announced a change in representative director effective April 1, 2026. Shinba Atsushi will transition from Representative Director, Vice President, Executive Officer and COO to Chairman of the Board of Directors.
2026-01-30
2345
💰 Equity
The company resolved at its 30th ordinary general meeting of shareholders on January 30, 2026, to issue stock options (新株予約権) to directors and employees of the company and its subsidiaries under particularly favorable conditions. A total of up to 5,000 stock warrants may be issued, with a maximum of 500,000 common shares as the underlying securities, at an exercise price determined by reference to recent market prices plus a 5% premium.
2026-01-30
1929
👤 CEO
The company's Board of Directors resolved on January 30, 2026 to execute a leadership transition effective April 1, 2026. Naoto Kami will become Representative Director and President (CEO), while Fumihiko Kajita and Jun Yamazaki will be appointed as Representative Directors and Vice Presidents (COO and CMO respectively). Incumbent Representative Director and President Yasuo Wada will transition to Chairman of the Board.
2026-01-30
9104
👤 CEO
Toshinobu Shinoda resigned as Representative Director and Senior Executive Officer effective April 1, 2026. He will transition to the position of Director. The company filed this extraordinary report on January 30, 2026, following a board resolution regarding this executive change.
2026-01-30
5137
🤝 Acquisition
The company's Board of Directors resolved on January 29, 2026 to acquire additional shares of Interzone Co., Ltd., a subsidiary under the equity method, to convert it into a wholly-owned subsidiary. The acquisition increases the company's voting rights from 20.83% to 100%, with the transaction effective January 30, 2026.
2026-01-30
6455
💰 Buyback
Morita Holdings has resolved to distribute 40,669 treasury shares to the Morita Employee Stock Ownership Association (ESOA) as restricted stock grants under an employee incentive program. The shares will be allocated to eligible employees across seven salary grades, with distribution scheduled for April 28, 2026, at a price of 2,850 yen per share, totaling approximately 115.9 million yen.
¥116M
2026-01-30
9066
🤝 Merger
The company will conduct an absorption-type merger (吸収分割) effective April 1, 2026, with BCJ-98 (its wholly-owned parent company) as the surviving entity. Following the MBO implemented in May 2025 and the change in management structure, this reorganization aims to concentrate management resources on core logistics operations while enabling more agile business decision-making. The merger is classified as a simplified merger under the Companies Act, requiring no shareholder approval.
2026-01-30
6245
👤 CEO
The company's Board of Directors resolved on January 26, 2026 to appoint Munenori Yasui as an additional Representative Director, effective February 1, 2026. Yasui was previously a Senior Managing Director and will transition to Representative Director, bringing 44 years of company tenure and experience managing production and quality safety operations.
2026-01-30
256A
💰 Debt
The company executed a borrowing of 18,000 million yen on January 30, 2026, under a syndicated commitment line contract (total facility: 20,000 million yen) arranged by Mizuho Bank. The loan is unsecured with a repayment deadline of February 27, 2026, and is subject to financial covenants including minimum consolidated equity requirements and restrictions on consecutive reporting period losses.
¥18.0bn
2026-01-30
9554
💰 Debt
The company entered into a loan agreement with Mizuho Bank on January 29, 2026, for 1,500 million yen with a repayment deadline of January 31, 2033. The loan is unsecured but includes two financial covenants: maintaining consolidated equity at least 75% of the prior year-end level, and ensuring operating profit does not turn negative for two consecutive fiscal years.
¥1.5bn
Showing 1801–1850 of 2170
← Prev 37 / 44 Next →